New Use of Anti-parasitic Drug to Potentially Treat Cancer
Unprecedented use of niclosamide, an FDA-approved anti-parasitic drug, to kill p53-defective cancer cells. Clinicians and scientists from Singapore have discovered the unprecedented use of an...